H3D partners with Ersilia Open Source Initiative (EOSI) to apply AI/ML to the drug discovery pipeline

31 May 2021 - 07:45

H3D is partnering with Ersilia Open Source Initiative (EOSI), a UK-based non-profit organization specializing in artificial intelligence (AI)/ machine learning (ML) for drug discovery. 


The main objective of this collaboration is to develop AI/ML models tailored to key assays in H3D’s malaria and Tuberculosis (TB) drug discovery pipelines, arranged in the form of a virtual screening cascade. Large chemical libraries can then be filtered through this cascade prioritizing compounds and thereby reducing the attrition rate of the real (experimental) pipeline.


"We are excited about this partnership with Ersilia as we look to develop a multi-disciplinary platform based on AI and ML for accelerating the delivery of clinical candidates at H3D. This technology will nicely augment our in-house abilities and skills.” Prof Kelly Chibale, H3D Director


Please read our official press release here.


Image: Yuichiro Chino/Getty Images